Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Misop Han

Showing results (111-120 of 196) with videos related to

Pageof 20
Sort By:
The Prostate|January 24, 2014
Identification of men with the highest risk of early disease recurrence after radical prostatectomyDebasish Sundi, Vinson Wang, Phillip M Pierorazio, et al.
Urology|November 30, 2014
Racial disparities in oncologic outcomes after radical prostatectomy: long-term follow-upFarzana A Faisal, Debasish Sundi, John L Cooper, et al.
Regional Anesthesia and Pain Medicine|June 12, 2014
Spinal anesthesia does not impact prostate cancer recurrence in a cohort of men undergoing radical prostatectomy: an observational studyKenneth S Tseng, Sachin Kulkarni, Elizabeth B Humphreys, et al.
Urology|June 30, 2006
Lymphovascular invasion in radical prostatectomy specimens: prediction of adverse pathologic features and biochemical progressionStacy Loeb, Kimberly A Roehl, Xiaoying Yu, et al.
BJU International|November 15, 2008
Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level aloneDavid J Hernandez, Misop Han, Elizabeth B Humphreys, et al.
The Journal of Urology|November 21, 2017
Incidence of Extraprostatic Extension at Radical Prostatectomy with Pure Gleason Score 3 + 3 = 6 (Grade Group 1) Cancer: Implications for Whether Gleason Score 6 Prostate Cancer Should be Renamed "Not Cancer" and for Selection Criteria for Active SurveillanceOudai Hassan, Misop Han, Amy Zhou, et al.
BJU International|September 10, 2016
Pathological analysis of the prostatic anterior fat pad at radical prostatectomy: insights from a prospective seriesMark W Ball, Kelly T Harris, Zeyad R Schwen, et al.
Urologic Oncology|June 14, 2011
Preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomyPhillip M Pierorazio, Brian M Lin, Jeffrey K Mullins, et al.
The Journal of Urology|November 17, 2016
The Impact of Downgrading from Biopsy Gleason 7 to Prostatectomy Gleason 6 on Biochemical Recurrence and Prostate Cancer Specific MortalityWon Sik Ham, Heather J Chalfin, Zhaoyong Feng, et al.
Urology|March 10, 2015
Variability in Medicare utilization and payment among urologistsJoan S Ko, Heather Chalfin, Bruce J Trock, et al.
Pageof 20

Showing results (111-120 of 196) with videos related to

Sort By:
Pageof 20
The Prostate|January 24, 2014
Identification of men with the highest risk of early disease recurrence after radical prostatectomyDebasish Sundi, Vinson Wang, Phillip M Pierorazio, et al.
Urology|November 30, 2014
Racial disparities in oncologic outcomes after radical prostatectomy: long-term follow-upFarzana A Faisal, Debasish Sundi, John L Cooper, et al.
Regional Anesthesia and Pain Medicine|June 12, 2014
Spinal anesthesia does not impact prostate cancer recurrence in a cohort of men undergoing radical prostatectomy: an observational studyKenneth S Tseng, Sachin Kulkarni, Elizabeth B Humphreys, et al.
Urology|June 30, 2006
Lymphovascular invasion in radical prostatectomy specimens: prediction of adverse pathologic features and biochemical progressionStacy Loeb, Kimberly A Roehl, Xiaoying Yu, et al.
BJU International|November 15, 2008
Predicting the outcome of prostate biopsy: comparison of a novel logistic regression-based model, the prostate cancer risk calculator, and prostate-specific antigen level aloneDavid J Hernandez, Misop Han, Elizabeth B Humphreys, et al.
The Journal of Urology|November 21, 2017
Incidence of Extraprostatic Extension at Radical Prostatectomy with Pure Gleason Score 3 + 3 = 6 (Grade Group 1) Cancer: Implications for Whether Gleason Score 6 Prostate Cancer Should be Renamed "Not Cancer" and for Selection Criteria for Active SurveillanceOudai Hassan, Misop Han, Amy Zhou, et al.
BJU International|September 10, 2016
Pathological analysis of the prostatic anterior fat pad at radical prostatectomy: insights from a prospective seriesMark W Ball, Kelly T Harris, Zeyad R Schwen, et al.
Urologic Oncology|June 14, 2011
Preoperative characteristics of men with unfavorable high-Gleason prostate cancer at radical prostatectomyPhillip M Pierorazio, Brian M Lin, Jeffrey K Mullins, et al.
The Journal of Urology|November 17, 2016
The Impact of Downgrading from Biopsy Gleason 7 to Prostatectomy Gleason 6 on Biochemical Recurrence and Prostate Cancer Specific MortalityWon Sik Ham, Heather J Chalfin, Zhaoyong Feng, et al.
Urology|March 10, 2015
Variability in Medicare utilization and payment among urologistsJoan S Ko, Heather Chalfin, Bruce J Trock, et al.
Pageof 20